The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
24524217 |
65 |
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates. |
Hokkaido University |
27563406 |
128 |
Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors. |
Roche Pharma Research and Early Development |
30639896 |
42 |
Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles. |
Hangzhou Institute of Innovative Medicine |
30587447 |
3 |
Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators. |
Purdue University |
31801019 |
5 |
Novel Cell-Penetrating Peptide Conjugated Proteasome Inhibitors: Anticancer and Antifungal Investigations. |
University of Auckland |
17249727 |
8 |
Cinnabaramides A-G: analogues of lactacystin and salinosporamide from a terrestrial streptomycete. |
Intermed Discovery Gmbh (Imd) |
15780623 |
39 |
Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome. |
Numazu Bio-Medical Research Institute |
7608891 |
7 |
Potent inhibitors of proteasome. |
Cephalon |
11992770 |
19 |
Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome. |
Novartis Pharma |
29652143 |
22 |
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example. |
Monash University |